Group 1 - The core investment theme post-Spring Festival revolves around "price increases" and "revaluation of physical assets," particularly in resource, chemical, and midstream manufacturing sectors, leveraging China's pricing power amid global uncertainties [1][2] - The technology sector, particularly driven by AI, remains a key focus, with sub-sectors like computing power, applications, and robotics expected to remain active due to industrial catalysts [1][2] - The recovery of export chains, non-bank financials, and certain consumer and real estate chains are seen as important supplements to market trends under the backdrop of internal and external demand recovery [1] Group 2 - CITIC Securities emphasizes that price increases are a core configuration clue for Q1, with a focus on sectors like chemicals, non-ferrous metals, power equipment, and new energy, while also increasing exposure to undervalued insurance and brokerage stocks [2] - Historical data indicates that February and the period around the Spring Festival are strong for market movements, with small-cap stocks showing a 100% probability of rising from the Spring Festival to the Two Sessions [3] - Guojin Securities highlights the importance of balancing global physical assets against Chinese assets, recommending commodities like copper, aluminum, and oil, as well as sectors with global comparative advantages like equipment exports and domestic manufacturing [4] Group 3 - Industrial sectors experiencing structural price increases due to supply-demand gaps are primarily in midstream materials and manufacturing, with a focus on chemicals, steel, and high-end manufacturing [5] - The potential for recovery in the export chain is noted, particularly in industries with significant exposure to the U.S. market that will benefit from reduced tariffs [5] - The policy uncertainty surrounding tariffs and trade is expected to favor gold as a risk hedge, with market participants anticipating potential shifts in U.S. trade policy [6] Group 4 - Attention is drawn to the post-holiday inventory replenishment in commodities, with a continued positive outlook on technology applications, particularly in semiconductors and AI [7] - Quantum technology is highlighted as a sector receiving dual catalysts from policy and technological advancements, with significant developments in quantum key distribution networks [8] - The AI industry revolution is identified as a key investment theme, focusing on computing power, storage, and applications, with a strong emphasis on the performance of high-growth sectors [9] Group 5 - Localized opportunities are expected in AI applications linked to overseas trends and robotics associated with the Spring Festival, with a cautious approach to market movements anticipated [10] - The current bull market logic remains intact, with a recommendation for investors to maintain confidence despite short-term volatility, focusing on sectors with high securities ratios [11]

Group 1 - The investment activities are shifting from being solely AI-driven to a broader spectrum of real sectors, indicating a recovery in global manufacturing cycles supported by a smoother path for U.S. interest rate cuts [1][4] - The revaluation of Chinese assets is expected as capital flows back, promoting internal consumption and inflation cycles [1][4] - The report suggests specific asset allocation strategies, including physical assets like copper, aluminum, and oil, as well as sectors with global comparative advantages such as Chinese equipment exports and domestic manufacturing [1][4] Group 2 - The U.S. GDP growth for Q4 2025 was below expectations, primarily due to government spending disruptions, but investment in AI and non-AI sectors is showing signs of recovery [2] - The manufacturing PMI data indicates a global manufacturing recovery, with Europe exceeding expectations and the U.S. maintaining expansion, suggesting a positive outlook for the manufacturing sector [2] - The recent U.S. Supreme Court ruling on tariffs may ease domestic inflation pressures and support global export recovery, shifting the burden of inflation control from the Federal Reserve to other sectors [2] Group 3 - Commodity prices, particularly for industrial and precious metals, are experiencing high volatility, but there is a shift towards real industrial pricing rather than financial speculation [3] - The geopolitical risks and supply disruptions are expected to maintain a premium on industrial metals, while demand from tech giants for AI investments remains strong [3] - The focus on inflation control is shifting from the Federal Reserve to government actions, which may benefit commodities like gold as a hedge against economic uncertainty [3] Group 4 - The core of market style rebalancing is not about the existence of an AI bubble but rather the macroeconomic impacts of AI combined with monetary policy and major country policy choices [4] - The report emphasizes the importance of physical asset revaluation based on low inventory and stable demand, highlighting sectors such as oil, rare earths, and various manufacturing industries [4] - The report identifies opportunities in sectors benefiting from capital market expansion and a bottoming out of long-term asset returns, particularly in non-bank financials [4]

Global Assets: Rebalancing Continues - The current market rebalancing is based on internal and external recovery, with AI trading entering its second phase, leading to a focus on the actual impact of AI on various industries [3][13] - From February 16 to February 20, 2026, global risk assets showed an overall upward trend, but internal performance was mixed, with industrial, financial, and energy sectors gaining favor [3][13] - The focus has shifted from whether AI is a bubble to identifying the real industrial impacts and critical supply-demand issues as AI transitions from a thematic to a macro factor [3][13] Manufacturing Cycle Further Rising - The U.S. GDP data for Q4 2025 showed slower growth primarily due to government spending disruptions, while AI-related investments remained strong [4][25] - Non-AI and residential investment growth is showing signs of bottoming out, indicating a broader recovery in investment activities beyond just AI [4][25] - The February manufacturing PMI data indicated a recovery in global manufacturing, with Europe exceeding expectations and the U.S. maintaining expansion, suggesting a positive trend in manufacturing cycles [4][25][34] Commodities: Transitioning from Financial Overtrading to Industrial Pricing - Recent fluctuations in industrial and precious metals prices are attributed to macro and industrial events, with a return to real supply-demand signals expected [5][44] - Geopolitical risks continue to support industrial metal prices, while demand from tech giants for AI investments remains robust, indicating a potential new support for demand [5][44] - Historical data suggests that current copper and aluminum price ratios are low compared to historical manufacturing PMI levels, indicating potential for price recovery [5][44][45] Focus on Global Physical Assets vs. Chinese Assets - The core of market rebalancing is not about the existence of an AI bubble but rather the macro impacts of AI combined with monetary and major country policy choices [6][56] - The relative smooth path for future U.S. interest rate cuts is expected to support the recovery of the global manufacturing cycle, which may lead to a revaluation of Chinese asset capacity [6][56] - Specific investment recommendations include physical assets like copper, aluminum, and oil, as well as sectors benefiting from capital inflows and consumption recovery in China [6][56]

中国经济网北京2月23日讯 颖泰生物(920819.BJ)近日披露2025年年度业绩快报公告。报告期内，公 司预计可实现营业收入为55.31亿元，较上年同期下降2.27%；归属于上市公司股东的净利润预计为-2.50 亿元，较上年同期上升57.45%；归属于上市公司股东的扣除非经常性损益的净利润预计为-2.74亿元， 较上年同期上升53.91%。 | | | | | T LA / U | | --- | --- | --- | --- | --- | | | 2024 年 | 2023 年 | 本年比上年 | 2022 年 | | | | | 增减% | | | 营业收入 | 5, 659, 103, 023. 14 | 5, 694, 589, 619. 24 | -0. 62% | 7, 823, 181, 672. 96 | | 扣除的与主营业务无关 | | | | | | 的业务收入、不具备商 | 57,790,633.96 | 93,562, 484. 42 | -38. 23% | - | | 业实质的收入金额 | | | | | | 扣除与主营业务无关的 | | | | | | 业务收入、不具备商 ...

2月17日，远大作物科学（陕西）有限公司原药车间内，工作人员在检消设备。 本报记者 梁少飞摄 2月20日，工人在西安东站安装正立面幕墙。 本报记者 陈志涛摄 春节假期，陕西延长中煤榆林能源化工股份有限公司不停工。图为2月20日拍摄的公司一角。 本报记者 苏欣雨摄 岁序更替，春潮涌动，丙午马年的新春暖意浸润三秦大地。 当千家万户围坐餐桌、共话团圆时，有这样一群建设者，他们坚守在项目工地、生产车间、能源保供一线，抢工期、保供应、抓生产， 不负美好春光。 重点工程加速冲刺 "扫描角度再调5度。盯紧数据，千万不能漏帧。"2月20日，西安东站候车大厅内，"95后"张钊洋盯着扫描仪显示屏，不时提醒操作员。 作为9万平方米天花吊顶施工现场技术负责人，春节假期，张钊洋和团队主动留守，创新运用"分区扫描+数据降噪"技术，逐一校准4万余 块异曲面吊顶板的角度、尺寸，用数字化技术攻克毫米级安装精度难题。 西安东站，这座兼具唐风汉韵与低碳理念的西北特大型综合交通枢纽，正在建设者的手中加速成形。 今年春节是中铁十四局西安东站项目智能风管加工厂负责人齐乃龙在施工一线度过的第三个春节，这一切，只为给车站打造高效智能 的"呼吸系统"。 西安 ...

根据国家统计局数据显示：2025年12月中国化学农药原药(折有效成分100％)产量为33.8万吨，同比下降 0.3%；2025年1-12月中国化学农药原药(折有效成分100％)累计产量为411.7万吨，累计增长8.7%。 2020-2025年中国化学农药原药(折有效成分100％)产量统计图 上市企业：扬农化工（600486）,安道麦Ａ（000553）,先达股份（603086）,ST红太阳（000525）,诺普 信（002215）,利尔化学（002258）,润丰股份（301035）,新安股份（600596） 相关报告：智研咨询发布的《2026-2032年中国农药行业市场全景调研及前景战略研判报告》 数据来源：国家统计局，智研咨询整理 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 ...

生产不打烊 服务不停档 兰州新区铆足干劲冲刺首季"开门红" 龙马奋进开新局，新春实干正当时。2026年春节假期，兰州新区项目建设中心处处涌动着火热的生产热 潮。20余家规上工业企业坚守生产一线、全力稳产保供，甘肃莱安、何尉环保、泰邦化工源、托球生 物、瑞隆高新等重点企业开足马力、满负荷生产，车间机器轰鸣、生产线高速运转，工人们坚守岗位、 奋战新春，以昂扬奋进的姿态奏响春节稳产保供、冲刺首季"开门红"的奋进乐章。 走进托球生物科技（兰州）有限公司生产车间，自动化生产设备高速运转，工人们身着工装、各司其 职，熟练进行投料、监控、质检、包装等操作，车间内一派井然有序、繁忙高效的生产景象。作为江苏 托球农化股份有限公司全资子公司，企业深耕农药产品研发创新，已构建起杀菌剂、杀虫剂、植物生长 调节剂三大系列20余种剂型的产品矩阵，旗下溴菌腈原药凭借过硬品质斩获"中国高新技术博览会金 奖"，氟虫腈原药生产装置规模、工艺技术及产品质量均位居国内领先水平，产品畅销全国20余个省区 市。 在兰州瑞隆高新材料有限公司生产车间，各类机械设备有序轰鸣，标准化生产流水线全速运转，叉车来 回穿梭转运物料，工人们加班加点、争分夺秒赶制订单， ...

Core Viewpoint - The company, Andao Mai A (000553), is expected to report a net loss of 873 million to 1.233 billion yuan for the year 2025, indicating a reduction in losses compared to 2024 [1][2]. Financial Performance - The annual report for 2025 will be disclosed after the market closes on March 26, 2026, providing complete financial performance data including sales and net profit [2]. - The forecasted net loss for 2025 represents an improvement over the previous year's performance [2]. Business Development - The company's board approved the 2026 work plan on December 22, 2025, which includes engaging in derivative hedging activities with a maximum contract value of 5 billion USD per trading day and daily related transactions not exceeding 315.293 million yuan [3]. - The relevant proposals have been submitted for review at the shareholders' meeting scheduled for January 13, 2026, with the results to be announced later [3].

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 公司于2025年10月29日披露了《陕西美邦药业集团股份有限公司2025年第三季度报告》，公司2025年 前三季度实现营业收入6.09亿元，同比下降2.23%；实现归属于上市公司股东的净利润3619.61万元，同 比下降16.36%（以上数据未经审计）。敬请广大投资者注意投资风险。 公司股票于2026年2月10日、2月11日、2月12日连续3个交易日收盘价格涨幅偏离值累计超过20%，根据 《上海证券交易所交易规则》的有关规定，属于股票交易异常波动情形。公司于2026年2月13日披露了 《陕西美邦药业集团股份有限公司股票交易异常波动公告》（公告编号：2026-004）。 2026年2月13日，公司股票再次涨停。鉴于近期公司股价波动较大，现对公司有关事项和风险说明如 下： 一、公司主营业务未发生重大变化 公司主营业务为农药产品研发、生产、销售以及农业技术推广与服务，公司目前生产经营正常，主营业 务未发生重大变 ...

Group 1 - The core point of the article is that Meibang Co., Ltd. experienced significant stock price fluctuations, with a cumulative increase of over 20% in closing prices over three consecutive trading days from February 10 to 12, 2026, and a further limit-up on February 13, resulting in a total increase of 33.10% during this period [1] - The company's latest rolling price-to-earnings ratio stands at 130.16, which is significantly higher than the industry average of 31.99 [1] - For the first three quarters of 2025, the company reported revenue of 609 million yuan, a year-on-year decrease of 2.23%, and a net profit of 36.1961 million yuan, reflecting a year-on-year decline of 16.36% [1]